These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37110792)

  • 1. Systematic Studies on Anti-Cancer Evaluation of Stilbene and Dibenzo[
    Borys F; Tobiasz P; Poterała M; Fabczak H; Krawczyk H; Joachimiak E
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stilbene and dibenzo[b,f]oxepine derivatives as anticancer compounds.
    Garbicz D; Tobiasz P; Borys F; Pilżys T; Marcinkowski M; Poterała M; Grzesiuk E; Krawczyk H
    Biomed Pharmacother; 2020 Mar; 123():109781. PubMed ID: 31865147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
    Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
    Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
    Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin.
    Boichuk S; Syuzov K; Bikinieva F; Galembikova A; Zykova S; Gankova K; Igidov S; Igidov N
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
    Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy.
    Hawash M
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
    Tangutur AD; Kumar D; Krishna KV; Kantevari S
    Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin.
    Lin MS; Hong TM; Chou TH; Yang SC; Chung WC; Weng CW; Tsai ML; Cheng TR; Chen JJW; Lee TC; Wong CH; Chein RJ; Yang PC
    Eur J Med Chem; 2019 Nov; 181():111584. PubMed ID: 31419740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
    Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
    Li L; Jiang S; Li X; Liu Y; Su J; Chen J
    Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy.
    Sebastian J; Rathinasamy K
    Curr Drug Targets; 2023; 24(11):889-918. PubMed ID: 37519203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors.
    El-Sayed NF; El-Hussieny M; Ewies EF; El Shehry MF; Awad HM; Fouad MA
    Drug Dev Res; 2022 Apr; 83(2):485-500. PubMed ID: 34523738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent microtubule-destabilizing agents targeting for colchicine site by virtual screening, biological evaluation, and molecular dynamics simulation.
    Zhang H; Luo QQ; Hu ML; Wang N; Qi HZ; Zhang HR; Ding L
    Eur J Pharm Sci; 2023 Jan; 180():106340. PubMed ID: 36435355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.
    Cao TM; Durrant D; Tripathi A; Liu J; Tsai S; Kellogg GE; Simoni D; Lee RM
    Am J Hematol; 2008 May; 83(5):390-7. PubMed ID: 18175355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.